🇺🇸 FDA
Patent

US 12291560

Dimerizing agent regulated immunoreceptor complexes

granted A61KA61K2039/585A61K31/436

Quick answer

US patent 12291560 (Dimerizing agent regulated immunoreceptor complexes) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/585, A61K31/436, A61K35/28, A61K38/00